What Are The Core Performance Indicators for PCM( Phase Change Material) Applied in The Cold Chain Transport of Pharmaceuticals and Vaccines?

In the global pharmaceutical and vaccine cryogenic transportation system, cold chain stability directly determines the effectiveness and safety of biological formulations, vaccines, and reagents. Traditional ice cubes and ordinary gel ice packs have large temperature fluctuations and short cooling times, which can easily cause vaccine inactivation.

PCM phase change cold storage materials, with their core advantages of constant temperature cold storage, has become a core material of high-end vaccine cold chain boxes and medical insulated transportation equipment.

For overseas PCM importers, cold chain equipment manufacturers, and pharmaceutical cold chain integrators, it is very important to determine whether a PCM ice pack is suitable for vaccine transportation except consider the PCM price. The core performance indicators of PCM materials are what truly determine the success or failure of cold chain transportation. On this article, we will describe in detail the seven key parameters of PCMs suitable for international vaccine transportation accoring to our many-year experiences in pharmaceutical cold chain exports.

1. Precise Phase Transition Temperature, Adapted to the Specific Temperature Control Range for Vaccines

Temperature accuracy is the fundamental core of vaccine-grade PCM. The standard storage and transportation temperature for most conventional vaccines and biological reagents is 2℃–8℃, which requires precise temperature control of the corresponding PCM phase transition temperature. The industry-standard temperature range is 3℃–5℃.

Ordinary cold chain ice packs do not have a fixed phase transition point, and the temperature will continue to drop or rise rapidly, which can easily lead to problems such as freezing the vaccine at low temperatures or causing it to become ineffective due to excessive high temperatures.

High-quality medical PCM can be fixed at a constant phase transition temperature, firmly locking the vaccine within a safe temperature range in a passive cold chain environment even without power or external refrigeration, perfectly adapting to globally pharmaceutical cold chain temperature control standards.

2. High Latent Heat Storage Capacity Determines Long-Term Cold Insulation Capacity

The latent heat value directly represents the total cold storage capacity of PCM and is the key difference between ordinary cold chain materials and medical grade PCM. The higher the latent heat value, the more cold energy stored per unit volume of PCM material, resulting in stronger cold insulation endurance.

For complex overseas transportation environments such as the high temperatures of Southeast Asia, the humid heat of South America, and the extreme heat and sunlight of the Middle East, high latent heat PCM can achieve long-term constant temperature cold insulation for 72–120 hours. In scenarios involving long-distance sea freight, multiple transshipments, and delivery to remote areas, PCM effectively prevents temperature runaway during transit, meeting the time requirements for international vaccine cross-border transportation.

3. Stable Freezing Cycle Performance Reduces Long-term Costs

Vaccine cold chain equipment is used in high-frequency cycles, requiring the corresponding PCM ice packs to be repeatedly frozen and thawed. Inferior PCMs will exhibit problems such as stratification, failure, and temperature deviation after only a dozen freeze-thaw cycles.

Compliant export-grade medical PCMs, having undergone more than 50 standard freeze-thaw cycle tests, still maintain formula stability, show no phase change degradation, and exhibit no material stratification.

For overseas cold chain rental companies, medical institutions, and vaccine container manufacturers, it is very essential for them that the superior cycle performance of PCM can significantly reduce consumable replacement costs, offering far greater cost-effectiveness than ordinary ice packs.

4. Superior Leakage Resistance and Physical Structural Stability

Vaccine and pharmaceutical transportation requires extremely high cleanliness standards. Leakage from PCM ice packs will directly contaminate medicines, vaccines and reagents, resulting in the entire batch unusable.

Professional export-grade PCM ice packs utilize a high-strength HDPE hard-shell packaging process, combined with sealing edge technology, enabling them to withstand alternating high and low temperatures, long-distance travel, and high-altitude drop tests.

Even at -20℃ freezing and 45℃ high temperatures, the outer shell remains intact without cracking and the internal liquid does not leak, fully meeting the cleanliness and safety standards for pharmaceutical products transportation.

5. PCM: Non-toxic and Environmental-friendly Materials, Sompliant with International Medical Safety Standards

The safety of materials used in medical cold chain consumables is a crucial requirement for overseas procurement. PCMs for the European, American, South American, and Southeast Asian markets must be food-grade, medical-grade, non-toxic formulas, free of heavy metals and harmful chemicals, non-irritants.

Qualified vaccine-grade PCMs shall be FDA certified and non-toxic, without any pollution and not reacting chemically with vaccines or biological agents. They meet the import safety requirements of private medical institutions and cold chain companies in various countries.

6. High Adaptability to High and Low Temperature Environments, Suitable for Complex Global Climates

The climates of different overseas markets vary greatly. The Middle East is hot and arid, South America is hot and humid, and Southeast Asia experiences consistently high temperatures almost the whole year , this requires extremely high demands on the environmental adaptability of PCMs applied.

Ordinary ice packs are highly susceptible to environmental temperature changes, melting and failing rapidly in high-temperature environments. Customized medical PCMs have undergone high and low temperature environment simulation testing, maintaining stable performance in extreme environments ranging from -30℃ to 45℃. They are unaffected by exposure to sunlight, humidity, and freezing temperatures, making them suitable for cross-border vaccine transportation scenarios in all regions of the world.

7. Extremely Low Temperature Deviation Rate, Ensuring Compliance with Temperature Control Throughout the Transport Process

The core requirement of the vaccine cold chain is zero temperature deviation. Even a slight temperature deviation can lead to substandard transportation data and spoilage of the vaccine.

High-quality export PCMs have a temperature deviation error controlled within ±0.5℃, with a stable temperature control curve throughout the entire transport process, without sudden increases or decreases. This perfectly matches the temperature control recording requirements of disease control centers and pharmaceutical companies, ensuring data compliance, safety, and traceability for every vaccine shipment.

8. Conclusion

PCM ice packs truly suited for international vaccine and pharmaceutical cold chains are not ordinary refrigeration consumables, but professional cold chain products integrating precise temperature control, long-lasting cold storage, safety and stability, and weather resistance. These seven performance indicators are also the core evaluation criteria for overseas cold chain container manufacturers, pharmaceutical distributors, and cold chain integrators when purchasing PCM.

We, UniRule Biotech (Shanghai) Co., Ltd, specialize in PCM raw materials and finished PCM ice packs for vaccine and pharmaceutical cold chains. We can also customize PCM cold chain insulated boxes for different temperature zones according to customer needs. Our products are suitable for cold chain transportation scenarios in South America, Southeast Asia, the Middle East, and other countries. We support small-batch trial orders and customized development. For product inquiries, please Contact us via Email or WhatsApp.